Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 855-867
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.855
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.855
Linear indices - time domain | ||||
Parameters | Abbreviation meaning | Interpretation | ||
MNN (ms) | Mean of NN intervals | Long RR intervals are related to a lower heart rate, while short RR intervals denote a high heart rate. It reflects SANS and PANS modulations | ||
SDNN (ms) | Standard deviation of all NN intervals | Reflects the activity of both SANS and PANS | ||
rMSSD (ms) | The square root of the mean squared differences of successive NN intervals | Reflects the PANS activity | ||
NN50 (count) | Number of interval differences of successive NN intervals greater than 50 ms | Reflects the PANS activity | ||
pNN50 (%) | Percentage of successive RR intervals that differ by more than 50 ms | The proportion of NN50 divided by total number of NN, which also represents the PANS activity | ||
Linear indices - frequency domain | ||||
ULF (ms², Hz, %) | Ultra low frequency | Frequency range: 0-0.003 Hz. Commonly, it is not present in HRV results | ||
VLF (ms², Hz, %) | Very low frequency | Frequency range: 0.003-0.04 Hz. It is related to renin-angiotensin-aldosterone system, thermoregulation, peripheral vasomotor tonus and PANS activity | ||
LF (ms², Hz, nu, %) | Low frequency | Frequency range: 0.04-0.15 Hz. It represents the SANS and PANS activity, with a predominance of SANS influence | ||
HF (ms², Hz, nu, %) | High frequency | Frequency range: 0.15-0.4 Hz. It represents the PANS activity | ||
LF/HF | Ratio of LF-to-HF power | So-called sympathovagal index. It represents the sympathovagal balance, the autonomic state resulting from the SANS and PANS influences | ||
Total power (ms²) | Total power | It reflects both SANS and PANS influences, representing the components with frequency range ≤ 0.4 Hz |
- Citation: Duque A, Mediano MFF, De Lorenzo A, Rodrigues Jr LF. Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications. World J Diabetes 2021; 12(6): 855-867
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/855.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.855